These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38722338)

  • 21. Characterization of anti-MERS-CoV antibodies against various recombinant structural antigens of MERS-CoV in an imported case in China.
    Wang W; Wang H; Deng Y; Song T; Lan J; Wu G; Ke C; Tan W
    Emerg Microbes Infect; 2016 Nov; 5(11):e113. PubMed ID: 27826140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.
    Okba NMA; Widjaja I; van Dieren B; Aebischer A; van Amerongen G; de Waal L; Stittelaar KJ; Schipper D; Martina B; van den Brand JMA; Beer M; Bosch BJ; Haagmans BL
    Emerg Microbes Infect; 2020 Dec; 9(1):1080-1091. PubMed ID: 32471334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013.
    Meyer B; Müller MA; Corman VM; Reusken CB; Ritz D; Godeke GJ; Lattwein E; Kallies S; Siemens A; van Beek J; Drexler JF; Muth D; Bosch BJ; Wernery U; Koopmans MP; Wernery R; Drosten C
    Emerg Infect Dis; 2014 Apr; 20(4):552-9. PubMed ID: 24655412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.
    Okba NMA; Raj VS; Widjaja I; GeurtsvanKessel CH; de Bruin E; Chandler FD; Park WB; Kim NJ; Farag EABA; Al-Hajri M; Bosch BJ; Oh MD; Koopmans MPG; Reusken CBEM; Haagmans BL
    Emerg Infect Dis; 2019 Oct; 25(10):1868-1877. PubMed ID: 31423970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.
    Harcourt JL; Rudoler N; Tamin A; Leshem E; Rasis M; Giladi M; Haynes LM
    Zoonoses Public Health; 2018 Sep; 65(6):749-754. PubMed ID: 29855166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
    Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
    Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Fc Fusion on Folding and Immunogenicity of Middle East Respiratory Syndrome Coronavirus Spike Protein.
    Chun J; Cho Y; Park KH; Choi H; Cho H; Lee HJ; Jang H; Kim KH; Oh YK; Kim YB
    J Microbiol Biotechnol; 2019 May; 29(5):813-819. PubMed ID: 30982320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice.
    Alharbi NK; Padron-Regalado E; Thompson CP; Kupke A; Wells D; Sloan MA; Grehan K; Temperton N; Lambe T; Warimwe G; Becker S; Hill AVS; Gilbert SC
    Vaccine; 2017 Jun; 35(30):3780-3788. PubMed ID: 28579232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an antibody-dependent cellular cytotoxicity reporter assay for measuring anti-Middle East Respiratory Syndrome antibody bioactivity.
    Cao J; Wang L; Yu C; Wang K; Wang W; Yan J; Li Y; Yang Y; Wang X; Wang J
    Sci Rep; 2020 Oct; 10(1):16615. PubMed ID: 33024203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.
    Qiu H; Sun S; Xiao H; Feng J; Guo Y; Tai W; Wang Y; Du L; Zhao G; Zhou Y
    Antiviral Res; 2016 Aug; 132():141-8. PubMed ID: 27312105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
    Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK
    J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a diagnostic system for detection of specific antibodies and antigens against Middle East respiratory syndrome coronavirus.
    Lee K; Ko HL; Lee EY; Park HJ; Kim YS; Kim YS; Cho NH; Park MS; Lee SM; Kim J; Kim H; Seong BL; Nam JH
    Microbiol Immunol; 2018 Sep; 62(9):574-584. PubMed ID: 30117617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live-attenuated bivalent measles virus-derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model.
    Bodmer BS; Fiedler AH; Hanauer JRH; Prüfer S; Mühlebach MD
    Virology; 2018 Aug; 521():99-107. PubMed ID: 29902727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.
    Deng Y; Lan J; Bao L; Huang B; Ye F; Chen Y; Yao Y; Wang W; Qin C; Tan W
    Emerg Microbes Infect; 2018 Apr; 7(1):60. PubMed ID: 29618723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
    Harvey R; Mattiuzzo G; Hassall M; Sieberg A; Müller MA; Drosten C; Rigsby P; Oxenford CJ;
    Emerg Infect Dis; 2019 Oct; 25(10):1878-1883. PubMed ID: 31423969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection.
    Houser KV; Gretebeck L; Ying T; Wang Y; Vogel L; Lamirande EW; Bock KW; Moore IN; Dimitrov DS; Subbarao K
    J Infect Dis; 2016 May; 213(10):1557-61. PubMed ID: 26941283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development.
    Mubarak A; Alturaiki W; Hemida MG
    J Immunol Res; 2019; 2019():6491738. PubMed ID: 31089478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    Kim MH; Kim HJ; Chang J
    PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
    Houser KV; Broadbent AJ; Gretebeck L; Vogel L; Lamirande EW; Sutton T; Bock KW; Minai M; Orandle M; Moore IN; Subbarao K
    PLoS Pathog; 2017 Aug; 13(8):e1006565. PubMed ID: 28817732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.